NLRP3 and gout: To date, it has been demonstrated that both soluble UA (sUA)16 and MSU can induce Nlrp3 (an NLR containing a pyrin domain as its N-terminal domain) oligomerization in mice, while the deposition of MSU activates Nlrp3 inflammasome in humans, in the context of gout 17.